Ray Dalio's PACB Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 102,761 shares of Pacific Biosciences of California, Inc. (PACB) worth $172,638, representing 0.00% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Ray Dalio has initiated a new position in PACB, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Pacific Biosciences of California (PACB) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pacific Biosciences of California (PACB) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +102,761 | New Buy | 102,761 | $1.68 |
Ray Dalio's Pacific Biosciences of California Investment FAQs
Ray Dalio first purchased Pacific Biosciences of California, Inc. (PACB) in Q2 2026, acquiring 102,761 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Pacific Biosciences of California, Inc. (PACB) for 1 quarters since Q2 2026.
Ray Dalio's largest addition to Pacific Biosciences of California, Inc. (PACB) was in Q2 2026, adding 102,761 shares worth $172,638.
According to the latest 13F filing for Q2 2026, Ray Dalio's firm, Bridgewater Associates, Lp, owns 102,761 shares of Pacific Biosciences of California, Inc. (PACB), valued at approximately $172,638.
As of the Q2 2026 filing, Pacific Biosciences of California, Inc. (PACB) represents approximately 0.00% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Pacific Biosciences of California, Inc. (PACB) was 102,761 shares, as reported at the end of Q2 2026.